Typhoid Fever Vaccines Market to Grow at a CAGR of 9.3% to reach US$ 525.32 Million from 2020 to 2027

Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, Others); Route of administration (Oral, Injectable), and Geography.

Publication Month: Oct 2020 | Report Code: TIPRE00003752 | No. of Pages: 141 | Category: Pharmaceuticals | Status: Published
Covid

The Typhoid fever vaccines Marketwas valued at US$ million262.81 in 2019and is projected to reach US$ 525.32 millionby 2027; it is expected to grow at a CAGR of 9.3%from 2020to 2027.

 

Typhoid is an infectious diseases caused due to contaminated food and water. Typhoid is a bacterial infection that can lead to a high fever and it is caused by the bacteria Salmonella typhi. This disease is rare in developed countries and vaccines are recommended in the areas where the disease is prevalent. There are two types of vaccines to prevent typhoid fever. One is an inactivated (killed) vaccine and the other is a live, attenuated (weakened) typhoid fever vaccine. Inactivated typhoid vaccine is administered as an injection.

                                       

The scope of the Typhoid fever vaccines market includes procedure Typhoid fever vaccines type, route of administration, and region. The market for Typhoid fever vaccinesis analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the Typhoid fever vaccines market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.


Lucrative Regions forTyphoid fever vaccines Market

Lucrative Regions forTyphoid fever vaccines Market

Get more information on this report :


 

Market Insights

Growing Number of Patients Suffering with Typhoid

Typhoid fever refers to a systemic infection caused by Salmonella Typhi that is usually ingested through contaminated water or food. The infectious disease is usually caused predominantly in association with lack of clean water and poor sanitization. Typhoid is known to be the most common fever in rural and underdeveloped economies. According to the recent estimates of the World Health Organization (WHO), typhoid is an endemic fever in Africa, Asia, Latin America, Oceania, and the Caribbean. The WHO also states that 80% of the typhoid fever cases arise from India, Bangladesh, China, Laos, Nepal, Indonesia, Vietnam, and Pakistan. As per the recent study by All India Institute of Medical Sciences (AIIMS), around 494 per 100,000 children of age group 5–15 years suffered from typhoid in 2017.

According to the Centers for Disease Control and Prevention (CDC), most of the typhoid fever cases in the US arise among international travelers. According to a study published in Lancet: Infectious Diseases, typhoid infects ~21.6 million people worldwide and is responsible for the deaths of estimated 200,000 people each year. Further, the economic instability in Latin America and some of the other underdeveloped economies have led to improper sanitation and limited access to clean water and food, which is leading to a high risk of typhoid incidence. According to the National Health Services (NHS), children experience the highest risk of typhoid infection worldwide due to growing stage of immunity among children.

Thus, the increasing incidence of typhoid fever and high risk of transmission through contaminated food and water are likely to propel the demand for typhoid vaccines, thereby supporting the market growth over the coming years.

 

Typhoid fever vaccines Type-BasedInsights         

Global Typhoid fever vaccines Market, based on Typhoid fever vaccines type, the Typhoid fever vaccines market is segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. In 2019, the capsular polysaccharide vaccinessegment accounted for the highest share of the market. Growth of this segment is attributed to the effectiveness associated with in preventing infectionsand increasing patient pool across the globe. The Live Attenuated Vaccine segment is likely to register highest CAGR in the global Typhoid fever vaccines market during the forecast period.

                                                                                                       

Global Typhoid fever vaccines Market, by Typhoid fever vaccines Type– 2019& 2027

Global Typhoid fever vaccines Market, by Typhoid fever vaccines Type– 2019& 2027

Get more information on this report :


 

Route of administration-BasedInsights

Global Typhoid fever vaccines Market, based on route of administration, the Typhoid fever vaccines market is segmented into oral and injections. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR of 10.1% in the market during the forecast period.

 

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frighteningespecially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world’s children below the 5-year-old age group.

 

Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategiesare commonly adopted by the market players in order to expand its product portfolio.

 

The market players operating in the Typhoid fever vaccines Market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

 

By Type

  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others

 

By Route of Administration                          

  • Oral
  • Injections


By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of the Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America (SAM)
    • Brazil
    • Argentina
    • Rest of South America

 

Company Profiles

  • Shanghai institute of biological products co., ltd.
  • Paxvax Inc.
  • PT Bio Farma
  • BIO-MED
  • BHARAT BIOTECH
  • Sanofi
  • GlaxoSmithKline plc.
  • Prokarium Ltd.
  • SCANDINAVIAN BIOPHARMA

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Typhoid Fever Vaccines Market – By Vaccine Type

1.3.2        Typhoid Fever Vaccines Market – By Route of Administration

1.3.3        Global Typhoid Fever Vaccines Market – By Geography

2.             Typhoid Fever Vaccines Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Typhoid Fever Vaccines– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.             Typhoid Fever Vaccines Market– Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Growing Number of Patients Suffering with Typhoid

5.1.2        Organizations Supporting Typhoid Immunizations

5.2       Market Restraint

5.2.1        Risk of Side-Effects Associated with Typhoid Fever Vaccines

5.3       Market Opportunity

5.3.1        Outsourcing Pharmaceutical Research

5.4       Future Trend

5.4.1        Development of Innovative and Potent Vaccine Candidates

5.5       Impact Analysis

6.             Typhoid Fever Vaccines Market – Global Analysis

6.1       Global Typhoid Fever Vaccines Marker Revenue Forecast And Analysis

6.2       Global Typhoid Fever Vaccines Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Typhoid Fever Vaccines Market – By Vaccine Type

7.1       Overview

7.2       Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

7.3       Live Attenuated Vaccine

7.3.1        Overview

7.3.2        Live Attenuated Vaccine : Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5       Capsular Polysaccharide Vaccines

7.5.1        Overview

7.5.2        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6       Conjugate Vaccine

7.6.1        Overview

7.6.2        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7       Others

7.7.1        Overview

7.7.2        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.             Typhoid Fever Vaccines Market Analysis – By Route of Administration

8.1       Overview

8.2       Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

8.2.1        Oral

8.2.1.1      Overview

8.2.2        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.3       Injectable

8.3.1        Overview

8.3.2        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.             Typhoid Fever Vaccines Market Analysis And Forecast To 2027 – Geographical Analysis

9.1       North America: Typhoid Fever Vaccines Market

9.1.1        Overview

9.1.2        North America: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.4        North America: Typhoid Fever Vaccines Market, by Route of Administration, 2018–2027 (USD Million)

9.1.5        North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

9.1.6        US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1      US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2      US: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.6.3      US: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.7        Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1      Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2      Canada: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.7.3      Canada: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.8        Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1      Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2      Mexico: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.8.3      Mexico: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.2       Europe: Typhoid Fever Vaccines Market

9.2.1        Overview

9.2.2        Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.2.3        Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.2.4        Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.2.5        Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)

9.2.6        Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.6.1      Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.6.2      Germany: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.2.6.3      Germany: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.2.7        UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.7.1      UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.7.2      UK: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.2.7.3      UK: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.2.8        France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.1      France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.8.2      France: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.2.8.3      France: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.2.9        Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.9.1      Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.9.2      Spain: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.2.9.3      Spain: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.2.10     Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.1    Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.10.2    Italy: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.2.10.3    Italy: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.2.11     Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.11.1    Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.2.11.2    Rest of Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.2.11.3    Rest of Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.3       Asia Pacific: Typhoid Fever Vaccines Market

9.3.1        Overview

9.3.2        Asia Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.3.3        Asia Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.3.4        Asia Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.3.5        Asia Pacific: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)

9.3.6        China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.1      China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.2      China: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.3.6.3      China: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.3.7        Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.1      Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.2      Japan: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.3.7.3      Japan: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.3.8        India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.1      India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.2      India: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.3.8.3      India: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.3.9        South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.1      South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.2      South Korea: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.3.9.3      South Korea: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.3.10     Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.1    Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.2    Australia: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.3.10.3    Australia: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.3.11     Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.11.1    Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.3.11.2    Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.3.11.3    Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.4       Middle East and Africa: Typhoid Fever Vaccines Market

9.4.1        Overview

9.4.2        Middle East and Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.4.3        Middle East and Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.4.4        Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.4.5        Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

9.4.6        Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.1      Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.2      Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.4.6.3      Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.4.7        UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.1      UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.2      UAE: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.4.7.3      UAE: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.4.8        South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.8.1      South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.8.2      South Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.4.8.3      South Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.4.9        Rest of Middle East & Africa (MEA): Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.9.1      Rest of MEA: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.4.9.2      Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.4.9.3      Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.5       South & Central America: Typhoid Fever Vaccines Market

9.5.1        Overview

9.5.2        South & Central America: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.5.3        South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.5.4        South & Central America: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.5.5        South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

9.5.6        Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.1      Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.2      Brazil: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.5.6.3      Brazil: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.5.7        Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.1      Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.2      Argentina: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.5.7.3      Argentina: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.5.8        Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.5.8.1      Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.5.8.2      Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.5.8.3      Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

10.          Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

10.1    North America: Impact Assessment of COVID-19 Pandemic

10.2    Europe: Impact Assessment of COVID-19 Pandemic

10.3    Asia Pacific: Impact Assessment of COVID-19 Pandemic

10.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

11.          Industry Landscape

11.1    Overview

11.2    Growth Strategies Done by the Companies in the Market, (%)

11.3    Organic Developments

11.3.1     Overview

11.4    Inorganic Developments

11.4.1     Overview

12.          Company Profiles

12.1    Shanghai institute of biological products co., ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    Paxvax Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    PT Bio Farma

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    BIO-MED

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    BHARAT BIOTECH

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Sanofi

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    GlaxoSmithKline plc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Prokarium Ltd.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    SCANDINAVIAN BIOPHARMA

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.          Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms

LIST OF TABLES

Table 1.             North America Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.             US Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             US Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 5.             Canada Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Canada Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 7.             Mexico Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Mexico Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 9.             Europe Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 10.          Europe Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.          Germany Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Germany Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 13.          UK Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          UK Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 15.          France Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          France Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 17.          Spain Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          Spain Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 19.          Italy Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 20.          Italy Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 21.          Rest of Europe Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Rest of Europe Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 23.          Asia Pacific Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 24.          Asia Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 25.          China Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          China Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 27.          Japan Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 28.          Japan Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 29.          India Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 30.          India Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 31.          South Korea Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 32.          South Korea Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 33.          Australia Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 34.          Australia Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 35.          Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 36.          Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 37.          Middle East & Africa: Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 38.          Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 39.          Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 40.          Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 41.          UAE: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 42.          UAE: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 43.          South Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 44.          South Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 45.          Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 46.          Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 47.          South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 48.          South & Central America: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 49.          Brazil: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 50.          Brazil: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 51.          Argentina: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 52.          Argentina: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 53.          Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 54.          Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 55.          Organic Developments Done By Companies

Table 56.          Inorganic Developments Done By Companies

Table 57.          Glossary of Terms, Typhoid Fever Vaccines Market

 

LIST OF FIGURES

Figure 1.           Typhoid Fever Vaccines Market Segmentation

Figure 2.           Typhoid Fever Vaccines Market – By Geography

Figure 3.           Typhoid Fever Vaccines Market Overview

Figure 4.           Live Attenuated Vaccine Segment Witness Fastest Growth

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           Typhoid Fever Vaccines Market, by Geography (US$ Million)

Figure 7.           Global Typhoid Fever Vaccines Market – Leading Country Markets (US$ Million)

Figure 8.           Global Typhoid Fever Vaccines Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraint

Figure 15.        Global Typhoid Fever Vaccines Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Typhoid Fever Vaccines Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Typhoid Fever Vaccines Market

Figure 18.        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

Figure 19.        Live Attenuated Vaccine : Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 24.        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        North America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.        North America Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 28.        North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

Figure 29.        US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Europe: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 33.        Europe Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 34.        Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)

Figure 35.        Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 39.        Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Asia Pacific: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 42.        Asia Pacific Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 43.        China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 45.        India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 47.        Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 48.        Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Middle East and Africa: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 50.        Middle East and Africa: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)

Figure 51.        Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

Figure 52.        Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 53.        UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        Rest of MEA: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        South & Central America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 57.        South & Central America: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)

Figure 58.        South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

Figure 59.        Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 60.        Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 61.        Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 62.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in North American Countries

Figure 63.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in European Countries

Figure 64.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Asia Pacific Countries

Figure 65.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Rest of the World

Figure 66.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Typhoid Fever Vaccines Market

  1. Shanghai institute of biological products co., ltd.
  2. BHARAT BIOTECH
  3. Sanofi
  4. GlaxoSmithKline plc.
  5. Paxvax Inc.
  6. PT Bio Farma
  7. BIO-MED
  8. Prokarium Ltd.
  9. Scandinavian Biopharma
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the typhoid fever vaccines market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global typhoid fever vaccinesmarket, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00003752
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Typhoid is an infectious diseases caused due to contaminated food and water. Typhoid is a bacterial infection that can lead to a high fever and it is caused by the bacteria Salmonella typhi. This disease is rare in developed countries and vaccines are recommended in the areas where the disease is prevalent. There are two types of vaccines to prevent typhoid fever. One is an inactivated (killed) vaccine and the other is a live, attenuated (weakened) typhoid fever vaccine. Inactivated typhoid vaccine is administered as an injection.

The factors that are driving growth of the market are Growing Number of Patients Suffering with Typhoid and Organizations Supporting Typhoid Immunizations are expected to boost the growth of the global Typhoid fever vaccines market.

The Typhoid fever vaccinesmarket majorly consists of the players such as Shanghai institute of biological products co., ltd., Paxvax Inc.,PT Bio Farma, BIO-MED, BHARAT BIOTECH, Sanofi, GlaxoSmithKline plc., Prokarium Ltd., Scandinavian Biopharmaand among others.

Pricing